284 related articles for article (PubMed ID: 26474448)
1. Persistent Tachypnea of Infancy. Usual and Aberrant.
Rauch D; Wetzke M; Reu S; Wesselak W; Schams A; Hengst M; Kammer B; Ley-Zaporozhan J; Kappler M; Proesmans M; Lange J; Escribano A; Kerem E; Ahrens F; Brasch F; Schwerk N; Griese M;
Am J Respir Crit Care Med; 2016 Feb; 193(4):438-47. PubMed ID: 26474448
[TBL] [Abstract][Full Text] [Related]
2. Role of High-Resolution Chest Computed Tomography in a Child with Persistent Tachypnoea and Intercostal Retractions: A Case Report of Neuroendocrine Cell Hyperplasia.
Lelii M; Patria MF; Pinzani R; Tenconi R; Mori A; Bonelli N; Principi N; Esposito S
Int J Environ Res Public Health; 2017 Sep; 14(10):. PubMed ID: 28946688
[No Abstract] [Full Text] [Related]
3. Familial neuroendocrine cell hyperplasia of infancy.
Popler J; Gower WA; Mogayzel PJ; Nogee LM; Langston C; Wilson AC; Hay TC; Deterding RR
Pediatr Pulmonol; 2010 Aug; 45(8):749-55. PubMed ID: 20623780
[TBL] [Abstract][Full Text] [Related]
4. Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy.
Balinotti JE; Maffey A; Colom A; Roldán O; Díaz W; Medín M; Racimo M; Teper A
Pediatr Pulmonol; 2021 Jun; 56(6):1681-1686. PubMed ID: 33580744
[TBL] [Abstract][Full Text] [Related]
5. High-resolution CT findings of pulmonary interstitial glycogenosis.
Weinman JP; White CJ; Liptzin DR; Deterding RR; Galambos C; Browne LP
Pediatr Radiol; 2018 Aug; 48(8):1066-1072. PubMed ID: 29687227
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series.
Gomes VC; Silva MC; Maia Filho JH; Daltro P; Ramos SG; Brody AS; Marchiori E
J Bras Pneumol; 2013; 39(5):569-78. PubMed ID: 24310630
[TBL] [Abstract][Full Text] [Related]
7. Exacerbations in neuroendocrine cell hyperplasia of infancy are characterized by increased air trapping.
Houin PR; Deterding RR; Young LR
Pediatr Pulmonol; 2016 Mar; 51(3):E9-12. PubMed ID: 26642007
[TBL] [Abstract][Full Text] [Related]
8. Ground-glass burden as a biomarker in neuroendocrine cell hyperplasia of infancy.
Spielberg DR; Brody AS; Baker ML; Woods JC; Towe CT
Pediatr Pulmonol; 2019 Jun; 54(6):822-827. PubMed ID: 30843378
[TBL] [Abstract][Full Text] [Related]
9. Early onset children's interstitial lung diseases: Discrete entities or manifestations of pulmonary dysmaturity?
Bush A; Griese M; Seidl E; Kerem E; Reu S; Nicholson AG
Paediatr Respir Rev; 2019 Apr; 30():65-71. PubMed ID: 30552058
[TBL] [Abstract][Full Text] [Related]
10. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy.
Kerby GS; Wagner BD; Popler J; Hay TC; Kopecky C; Wilcox SL; Quinones RR; Giller RH; Accurso FJ; Deterding RR
Pediatr Pulmonol; 2013 Oct; 48(10):1008-15. PubMed ID: 23169677
[TBL] [Abstract][Full Text] [Related]
11. Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD).
Yancheva SG; Velani A; Rice A; Montero A; Hansell DM; Koo S; Thia L; Bush A; Nicholson AG
Histopathology; 2015 Oct; 67(4):501-8. PubMed ID: 25684686
[TBL] [Abstract][Full Text] [Related]
12. Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.
Nevel RJ; Garnett ET; Worrell JA; Morton RL; Nogee LM; Blackwell TS; Young LR
Ann Am Thorac Soc; 2016 Aug; 13(8):1299-304. PubMed ID: 27187870
[TBL] [Abstract][Full Text] [Related]
13. French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial management.
Fabre C; Thumerelle C; Dervaux M; Abou-Taam R; Bihouee T; Brouard J; Clement A; Delacourt C; Delestrain C; Epaud R; Ghdifan S; Hadchouel A; Houdouin V; Labouret G; Perisson C; Reix P; Renoux MC; Troussier F; Weiss L; Mazenq J; Nathan N; Dubus JC
Eur J Pediatr; 2022 Aug; 181(8):3067-3073. PubMed ID: 35678871
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary interstitial glycogenosis associated with a spectrum of neonatal pulmonary disorders.
Cutz E; Chami R; Dell S; Langer J; Manson D
Hum Pathol; 2017 Oct; 68():154-165. PubMed ID: 28873355
[TBL] [Abstract][Full Text] [Related]
15. Isolated pulmonary interstitial glycogenosis associated with alveolar growth abnormalities: A long-term follow-up study.
Sardón O; Torrent-Vernetta A; Rovira-Amigo S; Dishop MK; Ferreres JC; Navarro A; Corcuera P; Korta-Murua J; Peña PG; Pérez-Belmonte E; Villares A; Camats N; Fernández-Cancio M; Carrascosa A; Pérez-Yarza EG; Moreno-Galdó A
Pediatr Pulmonol; 2019 Jun; 54(6):837-846. PubMed ID: 30912317
[TBL] [Abstract][Full Text] [Related]
16. Lung and airway shape in neuroendocrine cell hyperplasia of infancy.
Mastej EJ; DeBoer EM; Humphries SM; Cook MC; Hunter KS; Liptzin DR; Weinman JP; Deterding RR
Pediatr Radiol; 2018 Nov; 48(12):1745-1754. PubMed ID: 29955904
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine cell hyperplasia of infancy: an unusual cause of hypoxemia in children.
Caimmi S; Licari A; Caimmi D; Rispoli A; Baraldi E; Calabrese F; Marseglia GL
Ital J Pediatr; 2016 Sep; 42(1):84. PubMed ID: 27629751
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities.
Liptzin DR; Pickett K; Brinton JT; Agarwal A; Fishman MP; Casey A; Towe CT; Taylor JB; Kurland G; Hagood JS; Wambach J; Srivastava R; Al-Saleh H; Dell SD; Young LR; Deterding RR
Ann Am Thorac Soc; 2020 Jun; 17(6):724-728. PubMed ID: 32109152
[No Abstract] [Full Text] [Related]
19. Persistent tachypnea of infancy (PTI)--a new entity.
Deterding RR; Fan LL; Morton R; Hay TC; Langston C
Pediatr Pulmonol; 2001; Suppl 23():72-3. PubMed ID: 11886155
[No Abstract] [Full Text] [Related]
20. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism.
Doan ML; Elidemir O; Dishop MK; Zhang H; Smith EO; Black PG; Deterding RR; Roberts DM; Al-Salmi QA; Fan LL
Thorax; 2009 Aug; 64(8):677-81. PubMed ID: 19237389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
